Answers are grounded in this paper and cite their sources.
Evaluates urea biosensor performance, suggesting a novel approach for enhanced sensing accuracy.
This study presents a cost-effective enzymatic urea biosensor developed on a screen-printed carbon electrode (SPCE) using a sequential layer-by-layer modification strategy. A conductive polypyrrole (PPy) scaffold was electrochemically deposited to mitigate the restacking of reduced graphene oxide (rGO) sheets, creating a high-surface-area matrix for the covalent immobilization of urease (Urs). Evaluated in phosphate-buffered saline (PBS), the biosensor exhibited a linear response from PBS blank (0 mM) to 30 mM urea, with a calculated limit of quantification (LOQ) of 12.17 µM, a limit of detection (LOD) of 3.65 µM, and an area-normalized sensitivity of 3.68 µA·mM⁻¹·cm⁻². The device demonstrated high precision with relative standard deviations (RSDs) below 3%, robust storage stability (93% retention after 4 weeks), and good selectivity against physiological interferents. Beyond experimental testing, an explainable machine learning (ML) workflow was used as a supportive post hoc analysis to analyze the influence of fabrication variables and to benchmark urea concentration prediction against conventional electrochemical calibration. Overall, this work presents an engineering-optimized PPy/rGO/Urs modification strategy compatible with disposable SPCE fabrication for urea sensing in PBS and provides a transparent, ML-assisted data-analysis framework for sensor optimization and interpretation under controlled bench-validation conditions.
No takes yet. Share an insight, caveat, or question.
Jamaliyan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: